A Breakthrough in modern medicine and science
98 Alive™ Logo 98 Alive™ Header Image

History

Australian indigenous communities have used the Melaleuca alternifolia species of the native tea tree shrub as a topical medical treatment for centuries due to its antiseptic properties.

There are over 130 species in the Melaleuca family of which five have been found to have beneficial properties and are used in the preparation of treatment oils, often referred to commercially as ‘tea tree oil’.

Melaleuca alternifolia oil holds the greatest number of beneficial properties of those available and has therefore been adopted as a natural skin treatment globally. However, due to its potential toxicity the ability to consume it has been limited until now.

In 2001, a team of Australian scientists led by renowned microbiologist Professor Max Reynolds set out to resolve this limitation. Conducting careful, extensive global research and clinical trials, the team worked to extract the bulk of the monoterpenes in the overall finished product, reducing its toxicity and harnessing tea tree oil’s high number of beneficial properties.

The outcome was 98alive™, a natural medicine that is listed on the Australian Register of Therapeutic Goods.

UPDATE

We have now added a new section in Research called Special Reports from Professor Reynolds.

Just released:

A Natural Cleansing Bar to improve skin care and is made from MAC, olive oil, coconut oil, palm oil and shea butter. 98Alive Immune Support Syrup is available for those needing a liquid form of our capsules that is easier to take for those that struggle with the capsules or wanting to control the dosage more finely.

MAY 2016

Latest results of our research show that Melaleuca Alternifolia Leaf Concentrate kills West Nile Fever which until now had no cure. A world breakthrough in viral control.

Only 98Alive TM is developed with a unique formula that is patented in a number of countries including the USA and Australia.

Professor Reynolds was one of the five international Keynote speakers at the 3rd International Conference on Clinical Microbiology in Valencia Spain.